MEF2A Gene

Myocyte Enhancer Factor 2A: A Key Regulator of Cardiac Development and Coronary Artery Disease

Gene Information Card

Symbol MEF2A
Full Name Myocyte Enhancer Factor 2A
Gene Type Protein coding
Chromosomal Location 15q26.3
NCBI Gene ID 4205 ncbi.nlm.nih.gov/gene/4205
Ensembl ID ENSG00000168314
UniProt ID Q02078
OMIM ID 600660
HGNC ID 6995
Aliases MEF2, RSRFC4, RSRFC9

Description

MEF2A (myocyte enhancer factor 2A) is a transcription factor that belongs to the MEF2 family, which includes MEF2A, MEF2B, MEF2C, and MEF2D. It plays a critical role in cardiac and skeletal muscle development, differentiation, and function. MEF2A regulates gene expression by binding to MEF2 response elements in the promoters of target genes. Mutations in MEF2A have been associated with coronary artery disease (CAD) and myocardial infarction. The gene is expressed in multiple tissues, with highest levels in heart, skeletal muscle, and brain.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Coronary Artery Disease (CAD) MEF2A mutations (e.g., 7-amino acid deletion) disrupt transcription factor function, impairing vascular smooth muscle cell proliferation and leading to atherosclerosis. ClinVar, OMIM
Myocardial Infarction Loss-of-function mutations in MEF2A increase susceptibility to myocardial infarction by altering cardiac gene expression. OMIM, NCBI
Cardiomyopathy MEF2A dysregulation affects cardiac hypertrophy and remodeling pathways. NCBI, UniProt

Expression Profile

Tissue Expression
Tissue nTPM level
Heart 45.2 High
Skeletal Muscle 38.7 High
Brain 22.1 Medium
Lung 8.5 Low
Liver 3.2 Low
Cell Line Expression
Cell Line nTPM Notes
Cardiomyocytes 52.0 High expression in heart muscle cells
Skeletal muscle myoblasts 41.5 High expression during differentiation
Endothelial cells 12.3 Moderate expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1057_1063del (7-aa deletion) Deletion Rare Loss of function; associated with CAD
p.Pro279Leu Missense Rare Reduced DNA binding affinity
p.Arg319Trp Missense Rare Impaired transcriptional activity
Mutation functional classification

Loss of Function (LOF)

MEF2A mutations (e.g., 7-aa deletion) reduce or abolish transcriptional activation of target genes, leading to impaired cardiac and vascular function.

Gain of Function (GOF)

Not reported for MEF2A.

Dominant Negative (DN)

Some MEF2A mutants can interfere with wild-type MEF2A function, acting in a dominant-negative manner to suppress MEF2 target gene expression.

Gene Ontology (GO)

• DNA-binding transcription factor activity • RNA polymerase II transcription regulatory region sequence-specific DNA binding
• cardiac muscle cell development • skeletal muscle cell differentiation
• positive regulation of transcription by RNA polymerase II

Pathways

MEF2 signaling pathway
Cardiac muscle contraction
MAPK signaling pathway
Calcium signaling pathway

Protein Summary

MEF2A is a 507-amino acid protein that contains an N-terminal MADS-box domain and a MEF2 domain, which mediate DNA binding and dimerization. It forms homodimers or heterodimers with other MEF2 family members. The protein is phosphorylated by various kinases (e.g., p38 MAPK, CaMK) to regulate its activity. MEF2A is essential for cardiac morphogenesis and myogenesis.

Related Products

Product name Cat.No. Species Gene ID
MEF2A Knockout HEK293 Cell Line EDJ-KQ874 Human 4205 Details Get a Quote
MEF2A Knockout A-549 Cell Line EDJ-KQ21019 Human 4205 Details Get a Quote
MEF2A Knockout HCT 116 Cell Line EDJ-KQ21020 Human 4205 Details Get a Quote
MEF2A Knockout HeLa Cell Line EDJ-KQ21021 Human 4205 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: